IDHIRA: A prospective, multicenter, non-interventional study of ivosidenib in patients with IDH1 R132-mutated cholangiocarcinoma

25. Oktober 2024

Michl M, Hagemeyer N, Grebhardt S, Looss, M, Potthoff K, 2024, AbstractID: AS-DGHO-2024-00336 Posternumber: P1098